Effect of Eleutheroside E on an MPTP-Induced Parkinson’s Disease Cell Model and Its Mechanism
Open Access
Abstract
This research investigated the effects of eleutheroside E (EE) on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease cell model and its mechanism. Methods: To create a cell model of Parkinson’s disease, MPTP (2500 μmol/L) was administered to rat adrenal pheochromocytoma cells (PC-12) to produce an MPTP group. Selegiline (50 μmol/L) and MPTP had been administered to the positive group beforehand. The eleutheroside E group was divided into low-, medium-, and high-concentration groups, in which the cells were pretreated with eleutheroside E at concentrations of 100 μmol/L, 300 μmol/L, and 500 μmol/L. Next, MPTP was added to the cells separately. The CCK-8 method was used to measure the cell survival rate. Apart from the CCK-8 method, mitochondrial membrane potential detection, cell reactive oxygen species (ROS) detection, and other methods were also adopted to verify the effect of low, medium, and high concentrations of eleutheroside E on the MPTP-induced cell model. Western blot analysis was used to detect changes in the expression of intracellular proteins CytC, Nrf2, and NQO1 to clarify the mechanism. The results are as follows. Compared with the MPTP group, the survival rates of cells at low, medium, and high concentrations of eleutheroside E all increased. The mitochondrial membrane potential at medium and high concentrations of eleutheroside E increased. The ROS levels at medium and high concentrations of eleutheroside E decreased. Moreover, the apoptosis rate decreased and the expression levels of the intracellular proteins CytC, Nrf2, and NQO1 were upregulated. Conclusion: Eleutheroside E can improve the MPTP-induced apoptosis of PC-12 cells by increasing the mitochondrial membrane potential and reducing the level of intracellular reactive oxygen species (ROS). Moreover, the apoptosis of cells is regulated by the expression of CytC, Nrf2, and NQO1 proteins.Keywords
Funding Information
- the Zhuhai College of Science and Technology’s “Three Levels” Talent Construction Project (pdjh2023b0739)
- the 2023 Guangdong Science and Technology Innovation Strategic Climbing Project (pdjh2023b0739)
This publication has 22 references indexed in Scilit:
- Parkinson's Disease and ParkinsonismThe American Journal of Medicine, 2019
- Alterations in mitochondrial membrane potential in peripheral blood mononuclear cells in Parkinson’s Disease: Potential for a novel biomarkerRestorative Neurology and Neuroscience, 2018
- Parkinson’s disease from the gutBrain Research, 2018
- The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's DiseaseFrontiers in Pharmacology, 2017
- Mitochondrial Membrane Potential Assay2016
- Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS ReleasePhysiological Reviews, 2014
- Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harmsPhytomedicine, 2013
- A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s diseaseNeuroscience, 2013
- Acanthopanax senticosus: review of botany, chemistry and pharmacologyDie Pharmazie, 2011
- MPTP Toxicity: Implications for Research in Parkinson's DiseaseAnnual Review of Neuroscience, 1988